Viridian Therapeutics, Inc.\DE
VRDN Nasdaq
SEC CIK 1590750
Follow Viridian Therapeutics, Inc.\DE
Weekly email: filings, results
Revenue, last quarter
$25.8M
−63.5% vs same quarter last year
Net income
−$101.2M
−192.5% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$92.8M
−9.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $70.8M | −$342.6M |
| FY24 | $302K | −$269.9M |
| FY23 | $314K | −$237.7M |
| FY22 | $1.8M | −$129.9M |
| FY21 | $3M | −$79.4M |
| FY20 | $1.1M | −$110.7M |
| FY19 | $4.5M | −$41.9M |
| FY18 | $8.4M | −$32.7M |
| FY17 | $4M | −$26.5M |
| FY16 | $3.5M | −$17.3M |
| FY15 | $5.7M | −$11.3M |
| FY14 | $6.5M | −$7.9M |
| FY13 | $5.5M | −$2.2M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −512.9% | −483.6% |
| FY24 | - | −99018.2% | −89370.9% |
| FY23 | - | −81035% | −75700.6% |
| FY22 | - | −7579.2% | −7330.7% |
| FY21 | - | −2690.8% | −2679.7% |
| FY20 | - | −10512.4% | −10544.3% |
| FY19 | - | −941% | −938.6% |
| FY18 | - | −394.5% | −390% |
| FY17 | - | −662.8% | −662.3% |
| FY16 | 26.7% | −488.6% | −496.8% |
| FY15 | 56.7% | −196.1% | −198.5% |
| FY14 | 48.1% | −105.9% | −121.7% |
| FY13 | 49.4% | −3.6% | −39.3% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$276.9M |
| FY24 | −$232.8M |
| FY23 | −$185.1M |
| FY22 | −$94.6M |
| FY21 | −$54.9M |
| FY20 | −$29.8M |
| FY19 | −$36.1M |
| FY18 | −$27.3M |
| FY17 | −$28.4M |
| FY16 | −$15M |
| FY15 | −$7M |
| FY14 | −$2.5M |
| FY13 | −$1.2M |
| FY12 | - |
- Viridian Therapeutics, Inc.\DE
- Healthcare median
Show the numbers
| Year | Viridian Therapeutics, Inc.\DE | Healthcare median |
|---|---|---|
| FY25 | −483.6% | −30.6% |
| FY24 | −89370.9% | −47% |
| FY23 | −75700.6% | −58% |
| FY22 | −7330.7% | −80.4% |
| FY21 | −2679.7% | −71.9% |
| FY20 | −10544.3% | −62.2% |
| FY19 | −938.6% | −46.3% |
| FY18 | −390% | −49.6% |
| FY17 | −662.3% | −45.9% |
| FY16 | −496.8% | −36% |
| FY15 | −198.5% | −38.4% |
| FY14 | −121.7% | −35.5% |
| FY13 | −39.3% | −37.1% |
| FY12 | - | −29.1% |